Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma By Ogkologos - April 20, 2026 76 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the EMN24 IsKia study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Highlights the Importance of a Strong EU Commitment Towards Robust Science and Innovation Policies Following Meeting of EU Research Ministers on 29 May... Metastatic Breast Cancer: ESMO Clinical Practice Guideline EMA Recommends Extending Indications for Decitabine / Cedazuridine MOST POPULAR Cancer in My Community: Providing Free Access to Cancer Care in... September 17, 2020 Similar Disease-Free Survival with Extended Intermittent or Continuous Treatment with Letrozole... August 11, 2021 How to Talk About Cancer With Someone Who Has It August 24, 2021 FDA Approves Pembrolizumab and Berahyaluronidase alfa-pmph for Subcutaneous Injection October 2, 2025 Load more HOT NEWS FDA Approves Nivolumab and Ipilimumab Combination for Advanced Kidney Cancer New Treatment Approach Could Help Prevent Recurrences of Some Bladder Cancers Elderly Woman Seeks Trick-Or-Treaters Who Surprised Her With Gifts The Day... Advances in Gynaecological Cancer Research Could Change the Treatment Landscape
